Abstract Details

Title Strategic considerations for applying the flipped classroom to neurology education

Topic Research Methodology, �鶹��ýӳ��, and History

Presentation(s) P7 - Poster Session 7 (5:30 PM-6:30 PM)

Poster/Presentation
Number 13-010

Objective To explore the strategies for implementation and study of flipped classrooms in the field of neurology.

Background With ever-expanding amounts of core knowledge to impart, combined with augmented demands on neurological residents, exploring and, potentially, incorporating new methods of education are imperative. The flipped classroom model offers an opportunity for addressing these needs, as the work historically done in the classroom is moved outside. However, very few reports on the implementation of the flipped classroom in neurology have been published to date, and this educational model still represents a challenge for students and educators alike.

Design/Methods Members of the �鶹��ýӳ�� A.B. Baker Section on Neurological �鶹��ýӳ�� review reports of flipped classroom implementation in other medical/surgical subspecialties and in neurology, and discuss strategies to apply flipped classroom formats to neurology education.

Results The majority of publications lacks standardization of curricular formats in addition to lacking appropriate control groups or sufficient sample sizes. Early studies of the application of adult learning theory in medical education suggested a benefit. While most educational experiences have been well-received by learners, a number of obstacles to implementation exist: preparation time, cost, lack of compliance, lack of familiarity and experience among learners and educators. Given the increased investment required to develop and implement these curricular models, further study of best practices, focusing on types of content most amenable to non-traditional formats as well as how to quantify the balance of benefit and effort, are needed to guide the neurological field more broadly.

Conclusions Establishing a framework allowing an inter-institution collaboration and evaluation of program outcomes can pave the way for empirical research to identify optimal content areas (e.g., subspecialty education, skill acquisition, etc.) and contexts (e.g., subspecialty rotations vs core curricula) in which to apply flipped classrooms to neurology education.

Authors/Disclosures
Stefano Sandrone, PhD PRESENTER	Dr. Sandrone has nothing to disclose.
Jimmy V. Berthaud, MD (Methodist Healthcare)	Dr. Berthaud has nothing to disclose.
Chad Carlson, MD, F�鶹��ýӳ�� (Froedtert & Medical College of Wisconsin)	Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Jacquelyne Kane, MD (Evicore healthcare)	No disclosure on file
Neel Dixit, MD (VCU)	Dr. Dixit has nothing to disclose.
Amtul Farheen, MD, F�鶹��ýӳ�� (Jackson VA Medical Center)	Dr. Farheen has nothing to disclose.
Jessica B. Kraker, MD, F�鶹��ýӳ�� (Tulane University School of Medicine)	Dr. Kraker has or had stock in Doximity. An immediate family member of Dr. Kraker has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Kraker has received personal compensation in the range of $5,000-$9,999 for serving as a Peer instructor on surgical robot with Globus Medical.
James W. Owens, Jr., MD, PhD (University of Iowa Stead Family Department of Pediatrics)	Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Speare Law Firm. Dr. Owens has received personal compensation in the range of $500-$4,999 for serving as a Question Writer with �鶹��ýӳ��.
Gustavo A. Patino, MD, PhD (Western Michigan University Homer Stryker MD School of Medicine)	Dr. Patino has nothing to disclose.
Harini Sarva, MD, F�鶹��ýӳ�� (Weill Cornell Medical Center)	Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Daniel Weber, DO (St. Louis University)	Dr. Weber has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
Logan D. Schneider, MD (Stanford/VA Alzheimer's Center)	Dr. Schneider has received personal compensation for serving as an employee of Alphabet, Inc. Dr. Schneider has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Schneider has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Schneider has received intellectual property interests from a discovery or technology relating to health care.